{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:54:19Z","timestamp":1788440059108,"version":"build-2803163510"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1038\/s41401-020-00510-6","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T12:03:40Z","timestamp":1599134620000},"page":"1387-1394","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["CP-25, a compound derived from paeoniflorin: research advance on its pharmacological actions and mechanisms in the treatment of inflammation and immune diseases"],"prefix":"10.1038","volume":"41","author":[{"given":"Xue-zhi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"510_CR1","first-page":"5","volume":"23","author":"Z Jin","year":"2008","unstructured":"Jin Z. To explore the medicine of Cassia twig and Paeonia lactiflora in \u201cSynopsis of Golden Chamber\u201d. forum on traditional Chinese. Medicine. 2008;23:5\u20136.","journal-title":"Medicine."},{"key":"510_CR2","first-page":"339","volume":"36","author":"SH Ma","year":"2016","unstructured":"Ma SH, Wang HF, Liu JL, Huo XP, Zhao XR, Cao QW, et al. Inhibition of Paeoniflorin on TNF-\u03b1-induced TNF-\u03b1 receptor type I \/nuclear factor-\u03baB signal transduction in endothelial cells. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2016;36:339\u201344.","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"510_CR3","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1016\/S0040-4020(01)88953-5","volume":"28","author":"M Kaneda","year":"1972","unstructured":"Kaneda M, Litaka Y, Shibata S. The absolute structures of paeoniflorin, albiflorin, oxypaeoniflorin and benzoylpaeoniflorin isolated from chinese paeony root. Tetrahedron. 1972;28:4309\u201317.","journal-title":"Tetrahedron."},{"key":"510_CR4","first-page":"997","volume":"67","author":"C Wang","year":"2012","unstructured":"Wang C, Yuan J, Yang ZY, Nie XX, Song LH, Wei W. Pharmacokinetics of paeoniflorin microemulsion after repeated dosing in rats with adjuvant arthritis. Pharmazie. 2012;67:997\u20131001.","journal-title":"Pharmazie."},{"key":"510_CR5","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.2042-7158.1995.tb03293.x","volume":"47","author":"S Takeda","year":"1995","unstructured":"Takeda S, Isono T, Wakui Y, Matsuzaki Y, Sasaki H, Amagaya S, et al. Absorption and excretion of paeoniflorin in rats. J Pharm Pharmacol. 1995;47:1036\u201340.","journal-title":"J Pharm Pharmacol"},{"key":"510_CR6","first-page":"313","volume":"55","author":"JX He","year":"2003","unstructured":"He JX, Akao T, Tani T. Influence of co-administered antibiotics on the pharmacokinetic fate in rats of paeoniflorin and its active metabolite paeonimetabolin-I from Shaoyao-Gancao-tang. J Pharm Pharmacol. 2003;55:313\u201321.","journal-title":"J Pharm Pharmacol"},{"key":"510_CR7","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1055\/s-2003-45192","volume":"69","author":"SL Hsiu","year":"2003","unstructured":"Hsiu SL, Lin YT, Wen KC, Hou YC, Chao PD. A deglucosylated metabolite of paeoniflorin of the root of Paeonia lactiflora and its pharmacokinetics in rats. Planta Med. 2003;69:1113\u20138.","journal-title":"Planta Med."},{"key":"510_CR8","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1007\/s11095-006-9100-8","volume":"23","author":"ZQ Liu","year":"2006","unstructured":"Liu ZQ, Jiang ZH, Liu L, Hu M. Mechanisms responsible for poor oral bioavailability of paeoniflorin: Role of intestinal disposition and interactions with sinomenine. Pharm Res. 2006;23:2768\u201380.","journal-title":"Pharm Res."},{"key":"510_CR9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jep.2005.08.020","volume":"103","author":"K Chan","year":"2006","unstructured":"Chan K, Liu ZQ, Jiang ZH, Zhou H, Wong YF, Xu HX, et al. The effects of sinomenine on intestinal absorption of paeoniflorin by the everted rat gut sac model. J Ethnopharmacol. 2006;103:425\u201332.","journal-title":"J Ethnopharmacol."},{"key":"510_CR10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jep.2009.07.019","volume":"125","author":"H Wu","year":"2009","unstructured":"Wu H, Zhu Z, Zhang G, Zhao L, Zhang H, Zhu D, et al. Comparative pharmacokinetic study of paeoniflorin after oral administration of pure paeoniflorin, extract of Cortex Moutan and Shuang-Dan prescription to rats. J Ethnopharmacol. 2009;125:444\u20139.","journal-title":"J Ethnopharmacol."},{"key":"510_CR11","first-page":"2097","volume":"44","author":"X Yang","year":"2013","unstructured":"Yang X, Guo J, Xu W. Absorption and transport characteristic of paeoniflorin and its derivatives in model of Caco-2 cell monolayers. Chinese Traditional and Herbal. Chin Tradit Herb Drugs. 2013;44:2097\u2013104.","journal-title":"Chin Tradit Herb Drugs"},{"key":"510_CR12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jep.2009.12.040","volume":"129","author":"Y Cheng","year":"2010","unstructured":"Cheng Y, Peng C, Wen F, Zhang H. Pharmacokinetic comparisons of typical constituents in white peony root and sulfur fumigated white peony root after oral administration to mice. J Ethnopharmacol. 2010;129:167\u201373.","journal-title":"J Ethnopharmacol."},{"key":"510_CR13","unstructured":"Wang C, Yuan J, Wei W. Study on paeoniflorin-6\u2019O-benzene sulfonate\u2019s physicochemical property. Acta Univ Med Anhui. 2014;49:202\u20135."},{"issue":"5","key":"510_CR14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10787-018-0463-3","volume":"27","author":"M Zhao","year":"2019","unstructured":"Zhao M, Zhou P, Yu J, James A, Xiao F, Wang C, et al. The tissue distribution and excretion study of paeoniflorin-6\u2019-O-benzene sulfonate (CP-25) in rats. Inflammopharmacology. 2019;27:969\u201374.","journal-title":"Inflammopharmacology"},{"key":"510_CR15","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3109\/00498254.2015.1121553","volume":"46","author":"XD Yang","year":"2016","unstructured":"Yang XD, Wang C, Zhou P, Yu J, Asenso J, Ma Y, et al. Absorption characteristic of paeoniflorin-6\u2019-O-benzene sulfonate (CP-25) in in situ single-pass intestinal perfusion in rats. Xenobiotica. 2016;46:775\u201383.","journal-title":"Xenobiotica."},{"key":"510_CR16","first-page":"1751","volume":"53","author":"J Wang","year":"2018","unstructured":"Wang J, Wang C, Xiao F, Ma Y, Wei W. Study on absorption mechanism of paeoniflorin-6\u2019-O-benzene sulfonate (CP-25) in Caco-2 cells. Acta Univ Med Anhui. 2018;53:1751\u20136.","journal-title":"Acta Univ Med Anhui"},{"key":"510_CR17","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3109\/00498254.2016.1149633","volume":"46","author":"C Wang","year":"2016","unstructured":"Wang C, Yuan J, Zhang LL, Wei W. Pharmacokinetic comparisons of Paeoniflorin and Paeoniflorin-6\u2019O-benzene sulfonate in rats via different routes of administration. Xenobiotica. 2016;46:1142\u201350.","journal-title":"Xenobiotica."},{"key":"510_CR18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.drudis.2007.12.010","volume":"13","author":"G Szak\u00e1cs","year":"2008","unstructured":"Szak\u00e1cs G, V\u00e1radi A, Ozvegy-Laczka C, Sarkadi B. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug Discov Today. 2008;13:379\u201393.","journal-title":"Drug Discov Today"},{"key":"510_CR19","first-page":"1646","volume":"30","author":"C Wang","year":"2014","unstructured":"Wang C, Wei W. Research progress of pharmacokinetic study on paeoniflorin. Chin Pharmacol Bull. 2014;30:1646\u201350.","journal-title":"Chin Pharmacol Bull"},{"key":"510_CR20","doi-asserted-by":"crossref","first-page":"109432","DOI":"10.1016\/j.biopha.2019.109432","volume":"119","author":"H Tang","year":"2019","unstructured":"Tang H, Wu YJ, Xiao F, Wang B, Asenso J, Wang Y, et al. Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis. Biomed Pharmacother. 2019;119:109432.","journal-title":"Biomed Pharmacother."},{"key":"510_CR21","doi-asserted-by":"crossref","first-page":"108644","DOI":"10.1016\/j.biopha.2019.108644","volume":"112","author":"J Asenso","year":"2019","unstructured":"Asenso J, Yu J, Xiao F, Zhao M, Wang J, Wu Y, et al. Methotrexate improves the anti-arthritic effects of Paeoniflorin-6\u2019-O-benzene sulfonate by enhancing its pharmacokinetic properties in adjuvant-induced arthritis rats. Biomed Pharmacother. 2019;112:108644.","journal-title":"Biomed Pharmacother."},{"key":"510_CR22","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.biopha.2018.09.156","volume":"108","author":"YJ Wu","year":"2018","unstructured":"Wu YJ, Zhao MY, Wang J, Tang H, Wang B, Xiao F, et al. Absorption and efflux characteristics of CP-25 in plasma and peripheral blood mononuclear cells of rats by UPLC-MS\/MS. Biomed Pharmacother 2018;108:1651\u20137.","journal-title":"Biomed Pharmacother"},{"key":"510_CR23","first-page":"1006","volume":"7","author":"Shi Daohua","year":"2014","unstructured":"Daohua Shi, Jie Deng, Qiuyan Lian. Relationship between the protein concentration and total concentration of valproate acid in plasma on free concentration. Chin J Clin Pharmacol. 2014;7:1006\u20138.","journal-title":"Chin J Clin Pharmacol"},{"key":"510_CR24","doi-asserted-by":"crossref","unstructured":"Yu J, Xiao F, Asenso J, Peng Z, Yang XD, Wang C, et al. Simultaneous determination of paeoniflorin-6\u2032-O-benzene sulfonate (CP-25) and its active paeoniflorin (Pae) metabolite in rat plasma using UPLC-MS\/MS: an application for pharmacokinetic studies. RSC Adv. 2016;113209\u201318.","DOI":"10.1039\/C6RA22595K"},{"key":"510_CR25","volume":"6","author":"Y Chang","year":"2016","unstructured":"Chang Y, Jia X, Wei F, Wang C, Sun X, Xu S, et al. CP-25, a novel compound, protects against autoimmune arthritis by modulating immune mediators of inflammation and bone damage. Sci Rep. 2016;6:26239.","journal-title":"Sci Rep."},{"key":"510_CR26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3389\/fphar.2018.00563","volume":"9","author":"J Chen","year":"2018","unstructured":"Chen J, Wang Y, Wu H, Yan S, Chang Y, Wei W. A modified compound from paeoniflorin, CP-25, suppressed immune responses and synovium inflammation in collagen-induced arthritis mice. Front Pharmacol. 2018;9:563.","journal-title":"Front Pharmacol."},{"key":"510_CR27","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","volume":"389","author":"GR Burmester","year":"2017","unstructured":"Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet. 2017;389:2338\u201348.","journal-title":"Lancet."},{"key":"510_CR28","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrrheum.2017.128","volume":"13","author":"Y Tanaka","year":"2017","unstructured":"Tanaka Y. Rheumatoid arthritis: DMARD de-escalation - let the patient guide you. Nat Rev Rheumatol. 2017;13:637\u20138.","journal-title":"Nat Rev Rheumatol"},{"key":"510_CR29","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","volume":"389","author":"IB McInnes","year":"2017","unstructured":"McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. 2017;389:2328\u201337.","journal-title":"Lancet."},{"key":"510_CR30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/annrheumdis-2017-211871","volume":"77","author":"A Kavanaugh","year":"2018","unstructured":"Kavanaugh A, van Vollenhoven RF, Fleischmann R, Emery P, Sainsbury I, Florentinus S, et al. Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis. Ann Rheum Dis. 2018;77:289\u201392.","journal-title":"Ann Rheum Dis"},{"key":"510_CR31","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1166\/jbn.2015.2170","volume":"11","author":"E Nogueira","year":"2015","unstructured":"Nogueira E, Lager F, Le Roux D, Nogueira P, Freitas J, Charvet C, et al. Enhancing methotrexate tolerance with folate tagged liposomes in arthritic mice. J Biomed Nanotechnol. 2015;11:2243\u201352.","journal-title":"J Biomed Nanotechnol"},{"key":"510_CR32","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/ard.62.10.944","volume":"62","author":"D Aletaha","year":"2003","unstructured":"Aletaha D, Stamm T, Kapral T, Eberl G, Grisar J, Machold KP, et al. Survival and effectiveness of leflunomide compared with methotrexate and sulfasalazine in rheumatoid arthritis: a matched observational study. Ann Rheum Dis. 2003;62:944\u201351.","journal-title":"Ann Rheum Dis"},{"key":"510_CR33","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.intimp.2015.08.008","volume":"28","author":"N Xiang","year":"2015","unstructured":"Xiang N, Li XM, Zhang MJ, Zhao DB, Zhu P, Zuo XX, et al. Total glucosides of paeony can reduce the hepatotoxicity caused by Methotrexate and Leflunomide combination treatment of active rheumatoid arthritis. Int Immunopharmacol. 2015;28:802\u20137.","journal-title":"Int Immunopharmacol"},{"key":"510_CR34","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.intimp.2013.01.021","volume":"15","author":"Z Chen","year":"2013","unstructured":"Chen Z, Li XP, Li ZJ, Xu L, Li XM. Reduced hepatotoxicity by total glucosides of paeony in combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis. Int Immunopharmacol. 2013;15:474\u20137.","journal-title":"Int Immunopharmacol."},{"key":"510_CR35","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.biopha.2018.12.040","volume":"110","author":"X Yang","year":"2019","unstructured":"Yang X, Zhao Y, Jia X, Wang C, Wu Y, Zhang L, et al. CP-25 combined with MTX\/ LEF ameliorates the progression of adjuvant-induced arthritis by the inhibition on GRK2 translocation. Biomed Pharmacother. 2019;110:834\u201343.","journal-title":"Biomed Pharmacother."},{"key":"510_CR36","doi-asserted-by":"publisher","first-page":"106199","DOI":"10.1016\/j.intimp.2020.106199","volume":"80","author":"X Chen","year":"2020","unstructured":"Chen X, Zhang P, Liu Q, Zhang Q, Gu F, Xu S, et al. Alleviating effect of paeoniflorin-6\u2019-O-benzene sulfonate in antigen-inducedexperimental Sj\u00f6gren\u2019s syndrome by modulating B lymphocyte migrationvia CXCR5-GRK2-ERK\/p38 signaling pathway. Int Immunopharmacol. 2020;80:106199.\u00a0https:\/\/doi.org\/10.1016\/j.intimp.2020.106199.","journal-title":"Int Immunopharmacol"},{"key":"510_CR37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.rdc.2016.03.010","volume":"42","author":"FB Vivino","year":"2016","unstructured":"Vivino FB, Carsons SE, Foulks G, Daniels TE, Parke A, Brennan MT, et al. New treatment guidelines for Sj\u00f6gren\u2019s disease. Rheum Dis Clin N Am. 2016;42:531\u201351.","journal-title":"Rheum Dis Clin N Am"},{"key":"510_CR38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.intimp.2015.11.023","volume":"30","author":"H Li","year":"2016","unstructured":"Li H, Sun X, Zhang J, Sun Y, Huo R, Li H, et al. Paeoniflorin ameliorates symptoms of experimental Sjogren\u2019s syndrome associated with down-regulating Cyr61 expression. Int Immunopharmacol. 2016;30:27\u201335.","journal-title":"Int Immunopharmacol"},{"key":"510_CR39","doi-asserted-by":"crossref","first-page":"107452","DOI":"10.1016\/j.pharmthera.2019.107452","volume":"207","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wei W. Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. Pharmacol Ther. 2020;207:107452.","journal-title":"Pharmacol Ther"},{"key":"510_CR40","doi-asserted-by":"publisher","unstructured":"Gu F, Xu S, Zhang P, Chen X, Wu Y, Wang C, et al. CP-25 alleviates experimental Sj\u00f6gren\u2019s syndrome features in NOD\/Ltj mice and modulates T lymphocyte subsets.\u00a0Basic Clin Pharmacol Toxicol.\u00a02018;123:423\u201334. https:\/\/doi.org\/10.1111\/bcpt.13025.","DOI":"10.1111\/bcpt.13025"},{"key":"510_CR41","doi-asserted-by":"crossref","first-page":"e0147788","DOI":"10.1371\/journal.pone.0147788","volume":"11","author":"Y Wu","year":"2016","unstructured":"Wu Y, Chen W, Chen H, Zhang L, Chang Y, Yan S, et al. The elevated secreted immunoglobulin D enhanced the activation of peripheral blood mononuclear cells in rheumatoid arthritis. PLoS ONE. 2016;11:e0147788.","journal-title":"PLoS ONE."},{"key":"510_CR42","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/aps.2017.105","volume":"38","author":"YJ Wu","year":"2017","unstructured":"Wu YJ, Chen WS, Chen HS, Dai X, Dong J, Wang Y, et al. The immunoglobulin D Fc receptor expressed on fibroblast-like synoviocytes from patients with rheumatoid arthritis contributes to the cell activation. Acta Pharmacol Sin. 2017;38:1466\u201374.","journal-title":"Acta Pharmacol Sin"},{"key":"510_CR43","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fphar.2018.00004","volume":"9","author":"YJ Wu","year":"2018","unstructured":"Wu YJ, Chen HS, Chen WS, Dong J, Dong XJ, Dai X, et al. CP-25 attenuates the activation of CD4+ T cells stimulated with immunoglobulin D in human. Front Pharmacol. 2018;9:4.\u00a0https:\/\/doi.org\/10.3389\/fphar.2018.00004.","journal-title":"Front Pharmacol."},{"key":"510_CR44","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3389\/fphar.2017.00933","volume":"8","author":"F Zhang","year":"2017","unstructured":"Zhang F, Shu JL, Li Y, Wu YJ, Zhang XZ, Han L, et al. CP-25, a novel anti-inflammatory and immunomodulatory drug, inhibits the functions of activated human B cells through regulating BAFF and TNF-alpha signaling and comparative efficacy with biological agents. Front Pharmacol. 2017;8:933.","journal-title":"Front Pharmacol."},{"key":"510_CR45","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41401-018-0169-5","volume":"40","author":"JL Shu","year":"2019","unstructured":"Shu JL, Zhang XZ, Han L, Zhang F, Wu YJ, Tang XY, et al. Paeoniflorin-6\u2019-O-benzene sulfonate alleviates collagen-induced arthritis in mice by downregulating BAFF-TRAF2-NF-\u03baB signaling: comparison with biological agents. Acta Pharmacol Sin. 2019;40:801\u201313.","journal-title":"Acta Pharmacol Sin"},{"key":"510_CR46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2015.09.036","volume":"769","author":"Y Li","year":"2015","unstructured":"Li Y, Sheng K, Chen J, Wu Y, Zhang F, Chang Y, et al. Regulation of PGE2 signaling pathways and TNF-alpha signaling pathways on the function of bone marrow-derived dendritic cells and the effects of CP-25. Eur J Pharmacol. 2015;769:8\u201321.","journal-title":"Eur J Pharmacol"},{"key":"510_CR47","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s10787-019-00575-8","volume":"27","author":"XY Jia","year":"2019","unstructured":"Jia XY, Chang Y, Sun XJ, Wei F, Wu YJ, Dai X, et al. Regulatory effects of paeoniflorin-6\u2019-O-benzene sulfonate (CP-25) on dendritic cells maturation and activation via PGE2-EP4 signaling in adjuvant-induced arthritic rats. Inflammopharmacology. 2019;27:997\u20131010.","journal-title":"Inflammopharmacology."},{"key":"510_CR48","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/ard.2004.029751","volume":"64","author":"JJ Haringman","year":"2005","unstructured":"Haringman JJ, Gerlag DM, Zwinderman AH, Smeets TJ, Kraan MC, Baeten D, et al. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis. 2005;64:834\u20138.","journal-title":"Ann Rheum Dis"},{"key":"510_CR49","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bbrc.2020.03.164","volume":"526","author":"DD Wang","year":"2020","unstructured":"Wang DD, Jiang MY, Wang W, Zhou WJ, Zhang YW, Yang M, et al. Paeoniflorin-6\u2019-O-benzene sulfonate down-regulates CXCR4-G\u03b2\u03b3-PI3K\/AKT mediated migration in fibroblast-like synoviocytes of rheumatoid arthritis by inhibiting GRK2 translocation. Biochem Biophys Res Commun. 2020;526:805\u201312.","journal-title":"Biochem Biophys Res Commun"},{"key":"510_CR50","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/s41401-018-0196-2","volume":"40","author":"XY Jia","year":"2019","unstructured":"Jia XY, Chang Y, Wei F, Dai X, Wu YJ, Sun XJ, et al. CP-25 reverses prostaglandin E4 receptor desensitization-induced fibroblast-like synoviocyte dysfunction via the G protein-coupled receptor kinase 2 in autoimmune arthritis. Acta Pharmacol Sin. 2019;40:1029\u201339.","journal-title":"Acta Pharmacol Sin"},{"key":"510_CR51","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jep.2016.05.034","volume":"189","author":"X Jia","year":"2016","unstructured":"Jia X, Wei F, Sun X, Chang Y, Xu S, Yang X, et al. CP-25 attenuates the inflammatory response of fibroblast-like synoviocytes co-cultured with BAFF-activated CD4+ T cells. J Ethnopharmacol. 2016;189:194\u2013201.","journal-title":"J Ethnopharmacol."},{"key":"510_CR52","first-page":"6813016","volume":"2016","author":"X Yang","year":"2016","unstructured":"Yang X, Chang Y, Wei W. Endothelial dysfunction and inflammation: immunity in rheumatoid arthritis. Mediators Inflamm. 2016;2016:6813016.","journal-title":"Mediators Inflamm."},{"key":"510_CR53","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1042\/CS20191032","volume":"134","author":"CC Han","year":"2020","unstructured":"Han CC, Liu Q, Zhang Y, Li YF, Cui DQ, Luo TT, et al. CP-25 inhibits PGE2-induced angiogenesis by down-regulating EP4\/AC\/cAMP\/PKA-mediated GRK2 translocation. Clin Sci. 2020;134:331\u201347.","journal-title":"Clin Sci"},{"key":"510_CR54","first-page":"4831","volume":"20","author":"M Zhang","year":"2019","unstructured":"Zhang M, Gao M, Chen J, Song L, Wei W. CP-25 exerts anti-angiogenic effects on a rat model of adjuvant-induced arthritis by promoting GRK2-induced downregulation of CXCR4-ERK1\/2 signaling in endothelial cells. Mol Med Rep. 2019;20:4831\u201342.","journal-title":"Mol Med Rep"},{"key":"510_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-020-0453-0.","author":"H Wu","year":"2020","unstructured":"Wu H, Chen X, Gu F, Zhang P, Xu S, Liu Q, et al. CP-25 alleviates antigen-induced experimental Sj\u00f6gren\u2019s syndrome in mice by inhibiting JAK1-STAT1\/2-CXCL13 signaling and interfering with B-cell migration. Lab Investig. 2020. https:\/\/doi.org\/10.1038\/s41374-020-0453-0.","journal-title":"Lab Investig."},{"key":"510_CR56","doi-asserted-by":"crossref","first-page":"E1596","DOI":"10.3390\/cells8121596","volume":"8","author":"X Yang","year":"2019","unstructured":"Yang X, Li S, Zhao Y, Li S, Zhao T, Tai Y, et al. GRK2 mediated abnormal transduction of PGE2-EP4-cAMP-CREB signaling induces the imbalance of macrophages polarization in collagen-induced arthritis mice. Cells. 2019;8:E1596.","journal-title":"Cells."},{"key":"510_CR57","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/bs.ai.2017.05.003","volume":"136","author":"MD Steury","year":"2017","unstructured":"Steury MD, McCabe LR, Parameswaran N. G protein-coupled receptor kinases in the inflammatory response and signaling. Adv Immunol. 2017;136:227\u201377.","journal-title":"Adv Immunol"},{"key":"510_CR58","doi-asserted-by":"crossref","unstructured":"Hagen SA, Kondyra AL, Grocott HP, El-Moalem H, Bainbridge D, Mathew JP, et al. Cardiopulmonary bypass decreases G protein-coupled receptor kinase activity and expression in human peripheral blood mononuclear cells.\u00a0Anesthesiology.\u00a02003;98:343\u20138.","DOI":"10.1097\/00000542-200302000-00012"},{"key":"510_CR59","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1189\/jlb.0403136","volume":"75","author":"A Vroon","year":"2004","unstructured":"Vroon A, Heijnen CJ, Lombardi MS, Cobelens PM, Mayor F Jr, Caron MG, et al. Reduced GRK2 level in T cells potentiates chemotaxis and signaling in response to CCL4. J Leukoc Biol. 2004;75:901\u20139.","journal-title":"J Leukoc Biol"},{"key":"510_CR60","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1007\/s00018-019-03274-3","volume":"76","author":"P Penela","year":"2019","unstructured":"Penela P, Ribas C, S\u00e1nchez-Madrid F, Mayor F Jr. G protein-coupled receptor kinase 2 (GRK2) as a multifunctional signaling hub. Cell Mol Life Sci. 2019;76:4423\u201346.","journal-title":"Cell Mol Life Sci"},{"key":"510_CR61","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/jcp.10445","volume":"199","author":"F Grassi","year":"2004","unstructured":"Grassi F, Cristino S, Toneguzzi S, Piacentini A, Facchini A, Lisignoli G. XCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. J Cell Physiol. 2004;199:244\u201351.","journal-title":"J Cell Physiol"},{"key":"510_CR62","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/14397595.2015.1054088","volume":"26","author":"K Kanbe","year":"2016","unstructured":"Kanbe K, Chiba J, Inoue Y, Taguchi M, Yabuki A. SDF-1 and CXCR4 in synovium are associated with disease activity and bone and joint destruction in patients with rheumatoid arthritis treated with golimumab. Mod Rheumatol. 2016;26:46\u201350.","journal-title":"Mod Rheumatol."},{"key":"510_CR63","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.joca.2005.11.002","volume":"14","author":"M Whiteman","year":"2006","unstructured":"Whiteman M, Spencer JP, Zhu YZ, Armstrong JS, Schantz JT. Peroxynitrite-modified collagen-II induces p38\/ERK and NF-kappaB-dependent synthesis of prostaglandin E2 and nitric oxide in chondrogenically differentiated mesenchymal progenitor cells. Osteoarthr Cartil. 2006;14:460\u201370.","journal-title":"Osteoarthr Cartil."},{"key":"510_CR64","doi-asserted-by":"crossref","first-page":"29164","DOI":"10.1074\/jbc.M304314200","volume":"278","author":"A Elorza","year":"2003","unstructured":"Elorza A, Penela P, Sarnago S, Mayor F Jr. MAPK-dependent degradation of G protein-coupled receptor kinase 2. J Biol Chem. 2003;278:29164\u201373.","journal-title":"J Biol Chem"},{"key":"510_CR65","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1074\/jbc.M112.428078","volume":"288","author":"X Fu","year":"2013","unstructured":"Fu X, Koller S, Abd Alla J, Quitterer U. Inhibition of G-protein-coupled receptor kinase 2 (GRK2) triggers the growth-promoting mitogen-activated protein kinase (MAPK) pathway. J Biol Chem. 2013;288:7738\u201355.","journal-title":"J Biol Chem"},{"key":"510_CR66","first-page":"1860","volume":"21","author":"FL Han","year":"2017","unstructured":"Han FL, Liang F, Jiang TC, Liu M. Increased expression of CXCR5 and CXCL13 in mice with experimental autoimmune myocarditis. Eur Rev Med Pharmacol Sci. 2017;21:1860\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"510_CR67","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0092-8674(00)81798-5","volume":"87","author":"R F\u00f6rster","year":"1996","unstructured":"F\u00f6rster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 1996;87:1037\u201347.","journal-title":"Cell"},{"key":"510_CR68","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1515\/BC.2001.171","volume":"382","author":"G M\u00fcller","year":"2001","unstructured":"M\u00fcller G, Lipp M. Signal transduction by the chemokine receptor CXCR5: structural requirements for G protein activation analyzed by chimeric CXCR1\/CXCR5 molecules. Biol Chem. 2001;382:1387\u201397.","journal-title":"Biol Chem"},{"key":"510_CR69","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.immuni.2004.09.011","volume":"21","author":"AP Grech","year":"2004","unstructured":"Grech AP, Amesbury M, Chan T, Gardam S, Basten A, Brink R. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells. Immunity. 2004;21:629\u201342.","journal-title":"Immunity."},{"key":"510_CR70","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jep.2011.07.057","volume":"137","author":"Y Chang","year":"2011","unstructured":"Chang Y, Zhang L, Wang C, Jia XY, Wei W. Paeoniflorin inhibits function of synoviocytes pretreated by rIL-1\u03b1 and regulates EP4 receptor expression. J Ethnopharmacol. 2011;137:1275\u201382.","journal-title":"J Ethnopharmacol."},{"key":"510_CR71","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00011-013-0662-8","volume":"62","author":"C Wang","year":"2013","unstructured":"Wang C, Yuan J, Wu HX, Chang Y, Wang QT, Wu YJ, et al. Paeoniflorin inhibits inflammatory responses in mice with allergic contact dermatitis by regulating the balance between inflammatory and anti-inflammatory cytokines. Inflamm Res. 2013;62:1035\u201344.","journal-title":"Inflamm Res."},{"key":"510_CR72","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3892\/ijo.2013.2085","volume":"43","author":"JJ Wu","year":"2013","unstructured":"Wu JJ, Sun WY, Hu SS, Zhang S, Wei W. A standardized extract from Paeonia lactiflora and Astragalus membranaceus induces apoptosis and inhibits the proliferation, migration and invasion of human hepatoma cell lines. Int J Oncol. 2013;43:1643\u201351.","journal-title":"Int J Oncol"},{"key":"510_CR73","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.fitote.2003.08.016","volume":"75","author":"HO Yang","year":"2004","unstructured":"Yang HO, Ko WK, Kim JY, Ro HS. Paeoniflorin: an antihyperlipidemic agent from Paeonia lactiflora. Fitoterapia. 2004;75:45\u20139.","journal-title":"Fitoterapia."},{"key":"510_CR74","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.bjp.0706335","volume":"146","author":"DZ Liu","year":"2005","unstructured":"Liu DZ, Xie KQ, Ji XQ, Ye Y, Jiang CL, Zhu XZ. Neuroprotective effect of paeoniflorin on cerebral ischemic rat by activating adenosine A1 receptor in a manner different from its classical agonists. Br J Pharmacol. 2005;146:604\u201311.","journal-title":"Br J Pharmacol"},{"key":"510_CR75","doi-asserted-by":"crossref","first-page":"e33806","DOI":"10.1371\/journal.pone.0033806","volume":"7","author":"A Mushegian","year":"2012","unstructured":"Mushegian A, Gurevich VV, Gurevich EV. The origin and evolution of G protein-coupled receptor kinases. PLoS ONE. 2012;7:e33806.","journal-title":"PLoS ONE"},{"key":"510_CR76","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ceb.2013.10.005","volume":"27","author":"P Penela","year":"2014","unstructured":"Penela P, Nogu\u00e9s L, Mayor F Jr. Role of G protein-coupled receptor kinases in cell migration. Curr Opin Cell Biol. 2014;27:10\u20137.","journal-title":"Curr Opin Cell Biol"},{"key":"510_CR77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2016.05.010","volume":"111","author":"EV Gurevich","year":"2016","unstructured":"Gurevich EV, Gainetdinov RR, Gurevich VV. G protein-coupled receptor kinases as regulators of dopamine receptor functions. Pharmacol Res. 2016;111:1\u201316.","journal-title":"Pharmacol Res."},{"key":"510_CR78","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.phrs.2016.05.008","volume":"110","author":"J Hullmann","year":"2016","unstructured":"Hullmann J, Traynham CJ, Coleman RC, Koch WJ. The expanding GRK interactome: Implications in cardiovascular disease and potential for therapeutic development. Pharmacol Res. 2016;110:52\u201364.","journal-title":"Pharmacol Res."},{"key":"510_CR79","doi-asserted-by":"crossref","unstructured":"Ciccarelli M, Chuprun JK, Rengo G, Gao E, Wei Z, Peroutka RJ, et al. G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. Circulation. 2011;123:1953\u201362.","DOI":"10.1161\/CIRCULATIONAHA.110.988642"},{"key":"510_CR80","volume":"7","author":"Q Wang","year":"2017","unstructured":"Wang Q, Wang L, Wu L, Zhang M, Hu S, Wang R, et al. Paroxetine alleviates T lymphocyte activation and infiltration to joints of collagen-induced arthritis. Sci Rep. 2017;7:45364.","journal-title":"Sci Rep."},{"key":"510_CR81","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1021\/acs.jmedchem.5b02000","volume":"59","author":"HV Waldschmidt","year":"2016","unstructured":"Waldschmidt HV, Homan KT, Cruz-Rodr\u00edguez O, Cato MC, Waninger-Saroni J, Larimore KM, et al. Structure-based design, synthesis, and biological evaluation of highly selective and potent G protein-coupled receptor kinase 2 inhibitors. J Med Chem. 2016;59:3793\u2013807.","journal-title":"J Med Chem"},{"key":"510_CR82","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/mol.116.107185","volume":"91","author":"L Nogu\u00e9s","year":"2017","unstructured":"Nogu\u00e9s L, Reglero C, Rivas V, Neves M, Penela P, Mayor F Jr. G-protein-coupled receptor kinase 2 as a potential modulator of the hallmarks of cancer. Mol Pharmacol. 2017;91:220\u20138.","journal-title":"Mol Pharmacol."},{"key":"510_CR83","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cellsig.2017.04.002","volume":"41","author":"F Mayor Jr","year":"2018","unstructured":"Mayor F Jr, Cruces-Sande M, Arcones AC, Vila-Bedmar R, Briones AM, Salaices M, et al. G protein-coupled receptor kinase 2 (GRK2) as an integrative signalling node in the regulation of cardiovascular function and metabolic homeostasis. Cell Signal. 2018;41:25\u201332.","journal-title":"Cell Signal."},{"key":"510_CR84","first-page":"297","volume":"32","author":"W Wei","year":"2016","unstructured":"Wei W. Soft regulation of inflammatory immune responses. Chin Pharmacol Bull. 2016;32:297\u2013303.","journal-title":"Chin Pharmacol Bull"},{"key":"510_CR85","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/annrheumdis-2014-206028","volume":"74","author":"DL Boyle","year":"2015","unstructured":"Boyle DL, Soma K, Hodge J, Kavanaugh A, Mandel D, Mease P, et al. The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis. Ann Rheum Dis. 2015;74:1311\u20136.","journal-title":"Ann Rheum Dis"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00510-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00510-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00510-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T13:03:55Z","timestamp":1630674235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00510-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":85,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["510"],"URL":"https:\/\/doi.org\/10.1038\/s41401-020-00510-6","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"assertion":[{"value":"12 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}